Literature DB >> 965227

Human plasma levels of some anti-migraine drugs.

J Meier, E Schreier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 965227     DOI： 10.1111/j.1526-4610.1976.hed1603096.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  15 in total

1.  Pharmacokinetics and metabolism of [3H]-pipethiaden in healthy volunteers.

Authors:  Z Plecitá; M Spanĕl; I Ulc; V Rejŏlec; R Lapka
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Apr-Jun       Impact factor: 2.441

2.  Ciclazindol and mazindol on glucose uptake into human isolated skeletal muscle: no interaction of mazindol with methysergide.

Authors:  M J Kirby; P Turner
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Skin reactivity of unsensitized monkeys upon challenge with staphylococcal enterotoxin B: a new approach for investigating the site of toxin action.

Authors:  P H Scheuber; J R Golecki; B Kickhöfen; D Scheel; G Beck; D K Hammer
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

4.  Arterial complications of migraine treatment with methysergide and parenteral ergotamine.

Authors:  D A Joyce; S S Gubbay
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24

5.  Pharmacokinetics of intranasally-administered dihydroergotamine in the rat.

Authors:  D T Lau; Z Yu; R L Aun; A E Hassell; F L Tse
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

6.  Elucidation of the structure and receptor binding studies of the major primary, metabolite of dihydroergotamine in man.

Authors:  G Maurer; W Frick
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Migraine and drug absorption.

Authors:  G N Volans
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

8.  Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites.

Authors:  G Maurer; E Schreier; S Delaborde; H R Loosli; R Nufer; A P Shukla
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

9.  Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.

Authors:  J J Ibraheem; L Paalzow; P Tfelt-Hansen
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

10.  Ergotamine absorption and toxicity.

Authors:  D A Orton; R J Richardson
Journal:  Postgrad Med J       Date:  1982-01       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.